{"name":"Aulos Bioscience, Inc.","slug":"aulos-bioscience-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AU-007","genericName":"AU-007","slug":"au-007","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"AU-007","genericName":"AU-007","slug":"au-007","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNWTFjeFh5Vk5fb0RSNG14Q3YydHBIc050Y1BwRjgtNEREaS1mRXljblphdWhpbTVwQXV6WmdkelpmSjh6QjFSN01uN1VoeE82bGtLbS1Fay1vYlZSYl9ZMjBPSVQxU3RvbFR6ZUVLRmFNQ1IyMEg3azlLcjNYVzUtb01HdVBaQi1keTZ2RmtZZjdzcExXZkpRT0M0OXFTYkpBVEJ4UlN4Z0VZNVEwSHZjSlZaSDJzTXg2ZUxlaEduWQ?oc=5","date":"2025-12-10","type":"deal","source":"Fierce Biotech","summary":"Apple Tree Partners files for bankruptcy to keep cash flowing to portfolio biotechs - Fierce Biotech","headline":"Apple Tree Partners files for bankruptcy to keep cash flowing to portfolio biotechs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE9uSDlYWEpJYXdhQ2drQzhYOHJLd0twQ2Y1WE9rdGlISEk2ZngwWG9ETDNGMHpKQ2Utb0tVcGFNTGVvdEt6VjN1aWE0YWlMaThtd3l2TVdYQ3Z0cEw1RDJFZHlkZnU2WEZUMTdJdGd3ZHFzNUk?oc=5","date":"2025-10-15","type":"trial","source":"Taylor & Francis Online","summary":"HERTHENA-PanTumor01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated advanced solid tumors: Future Oncology: Vol 21, No 25 - Taylor & Francis Online","headline":"HERTHENA-PanTumor01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated advanced solid tumors: F","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAJBVV95cUxON3haaElHU09WM2UxVFAtWGQyRUtONkJKSURwc1E0bWVjVnRTVTRTVklWSFBiZURWLWgtQWhEcGFBNmZLM0FhTFFZeE5tWE90dnRVRzk2bVlVVFEzS3dtX3c5T3Y3allKd1E2UEhUbzJGdnk0SlR4Z2hsTkxHTy1XNTljamJJcnJ2WG5YVUd2RS1pWlE4aHp0WFR2TGU1WGcxa3Fabk0walIxdGZCXzg3amhpTkpJSm12ajR5akpkTVpuc1RaSUZKek1yZEc1WVFGWVkwSnZBX1Q2T0EtUmlaREM4eVl4T3RoRE1iZmpkTTk0VUM2NXRhdkdxc3ZNOEJMTVc3Zk5HcUp0bzdESU42OFN0cmQ1ZDFYX0JzdVZBV0gtZjY0cDQzUl9sQ01fSllFcjhhRA?oc=5","date":"2025-07-10","type":"trial","source":"GlobeNewswire","summary":"Interleukin-2 Inhibitors Clinical Trial Pipeline - GlobeNewswire","headline":"Interleukin-2 Inhibitors Clinical Trial Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPdE81SmVqT3Q3ZzZlNjAxUTZucFFseUdLMllHZE8yVmRsTm4yR1VZeHlnSDZfWl9pTzJ4TmZGOEg4OURBUEJ4Q28tZGV4RnhWczFfbXAtMDd1OTlqbENfVFpibHRXVUlxU0htaFRxckRtQlQ5Rm9jMk56RUlLSG42QXltaXJpTmZUWGxwZWVCcFZyTnJRY3lQS2x2eWdkNEtKeWZCdVVkNDlzOFByX2d1YmpsaFJacnFV?oc=5","date":"2024-11-08","type":"pipeline","source":"BioSpace","summary":"SITC: Aulos Bioscience Presents Strong Evidence of AU-007’s Anti-Tumor Activity - BioSpace","headline":"SITC: Aulos Bioscience Presents Strong Evidence of AU-007’s Anti-Tumor Activity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQSEMwazVrUGxVMnpkSWs1dUR0RGE5TFk5Ymt2aXdtQXNVNEluQUUyRHZEbnZrb0NiY25YdF95ZEZJMEg1dTRRbTlVTWdmaGI1Rk9DWXpKVE9xelBUbzNudVo3MlVjR0lhS3BEVnptN1ZqMWpnSXB1VnZXMC1CUURJbmcxWGE3aTVmaXhFRlQwUXZhekc4YXBvOHpDMHJGdlMwSEpBV1JOX08zVmF3a2w0bExCeVBnaXZiNEFRWE9GY0hqWGhYeUEw?oc=5","date":"2024-03-22","type":"deal","source":"Life Science Leader","summary":"Why Fusion Pharma Is The Latest Billion Dollar Big Pharma Buy In Radiopharmaceuticals - Life Science Leader","headline":"Why Fusion Pharma Is The Latest Billion Dollar Big Pharma Buy In Radiopharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE1jejRwTHAxQnFJR0NTSEhxUVdFamY3VTNxcEJnMWVKcEVzaEdScmRfYVUxajlydE4zeTZKRWRrMWc4T0g1N1ZCR3VYU0pxTDZ1a1F5MmlB?oc=5","date":"2024-02-17","type":"pipeline","source":"Yahoo! Finance Canada","summary":"Satellos Bioscience Inc. (MSCL.TO) Stock Price, News, Quote & History - Yahoo! Finance Canada","headline":"Satellos Bioscience Inc. (MSCL.TO) Stock Price, News, Quote & History - Yahoo! Finance Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNY0tzMVllcEJLaVF5SVY1VlpZUFJ0NkRCdlFmeF9yS09tbHUzT2ttNnBaaTFLQWRiYTRldkx1ajlMd1JQcXdzdFJ5YXlGT2pnaG9WX1NrSElnaVRwTy1Qa2I4U0xseTdOMi14UktuRUE3bmtad0RJWHEtSFNJU1hXTFRnLVZ0TnhzbFh2b3R1Q0JMZE4yNFhWR2s4SmdVdTdyTGxxVVRQc19ObXp0U1E?oc=5","date":"2022-01-31","type":"pipeline","source":"The Business Journals","summary":"Biotech startup picked up rebounded CEO. Here's why they think it's a good match. - The Business Journals","headline":"Biotech startup picked up rebounded CEO. Here's why they think it's a good match.","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}